title: Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis.
authors.affiliation: Amgen, Inc., Thousand Oaks, California 91320, USA.
authors.forename: Brad
authors.initials: B
authors.lastname: Bolon
authors.forename: Victoria
authors.initials: V
authors.lastname: Shalhoub
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Kostenuik
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Campagnuolo
authors.forename: Sean
authors.initials: S
authors.lastname: Morony
authors.forename: William J
authors.initials: WJ
authors.lastname: Boyle
authors.forename: Debra
authors.initials: D
authors.lastname: Zack
authors.forename: Ulrich
authors.initials: U
authors.lastname: Feige
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D019610:Cytoprotection; D006023:Glycoproteins / Q000627:therapeutic use*; D006801:Humans; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
chemical_list: D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human